Ogunshola F, Khan R, Ghebremichael M
BMC Res Notes. 2025; 18(1):6.
PMID: 39773670
PMC: 11707843.
DOI: 10.1186/s13104-024-07032-y.
Ghebremeskel G, Mengistu S, Tsegai M, Mehretab A, Kidane H, Abraham Y
HIV AIDS (Auckl). 2024; 16:433-453.
PMID: 39524019
PMC: 11550920.
DOI: 10.2147/HIV.S483094.
Zaongo S, Zongo A, Chen Y
Front Immunol. 2024; 15:1470308.
PMID: 39257582
PMC: 11383789.
DOI: 10.3389/fimmu.2024.1470308.
Ogunshola F, Khan R, Ghebremichael M
Res Sq. 2024; .
PMID: 38699317
PMC: 11065074.
DOI: 10.21203/rs.3.rs-4243586/v1.
Seng R, Frange P, Faye A, Dollfus C, Chenadec J, Boufassa F
Lancet Reg Health Eur. 2024; 40:100885.
PMID: 38576825
PMC: 10993179.
DOI: 10.1016/j.lanepe.2024.100885.
Combining CD4 count, CD8 count and CD4/CD8 ratio to predict risk of mortality among HIV-positive adults after therapy: a group-based multi-trajectory analysis.
Ma J, Wang G, Zhu X, Li L, Wang L, Hao L
Front Immunol. 2023; 14:1269650.
PMID: 38124745
PMC: 10731246.
DOI: 10.3389/fimmu.2023.1269650.
Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants.
Fray E, Wu F, Simonetti F, Zitzmann C, Sambaturu N, Molina-Paris C
Cell Host Microbe. 2023; 31(3):356-372.e5.
PMID: 36809762
PMC: 10583177.
DOI: 10.1016/j.chom.2023.01.016.
Quantification of CD4 Recovery in Early-Treated Infants Living With HIV.
Schroter J, Anelone A, De Boer R
J Acquir Immune Defic Syndr. 2022; 89(5):546-557.
PMID: 35485581
PMC: 8901030.
DOI: 10.1097/QAI.0000000000002905.
Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients.
Kumar G, Cottalorda-Dufayard J, Garraffo R, De Salvador-Guillouet F, Cua E, Roger P
Cells. 2022; 11(2).
PMID: 35053324
PMC: 8773801.
DOI: 10.3390/cells11020208.
Fighting HIV-1 Persistence: At the Crossroads of "Shoc-K and B-Lock".
Acchioni C, Palermo E, Sandini S, Acchioni M, Hiscott J, Sgarbanti M
Pathogens. 2021; 10(11).
PMID: 34832672
PMC: 8622007.
DOI: 10.3390/pathogens10111517.
Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity.
Ye J, Gao Y, Ji M, Yang Y, Wang Z, Wang B
J Immunother Cancer. 2021; 9(7).
PMID: 34272308
PMC: 8287630.
DOI: 10.1136/jitc-2021-002753.
Anti-Tat immunity defines CD4 T-cell dynamics in people living with HIV on long-term cART.
Tripiciano A, Picconi O, Moretti S, Sgadari C, Cafaro A, Francavilla V
EBioMedicine. 2021; 66:103306.
PMID: 33839064
PMC: 8105504.
DOI: 10.1016/j.ebiom.2021.103306.
Immunological Response During HAART and Determinants of Current CD4 T-Cell Count Among HIV/AIDS Patients Attending University of Gondar Referral Hospital, Northwest Ethiopia.
Manaye G, Abateneh D, Kebede K, Belay A
HIV AIDS (Auckl). 2020; 12:295-306.
PMID: 32801928
PMC: 7411274.
DOI: 10.2147/HIV.S255751.
Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections.
Anderson E, Simonetti F, Gorelick R, Hill S, Gouzoulis M, Bell J
Viruses. 2020; 12(2).
PMID: 31991737
PMC: 7077288.
DOI: 10.3390/v12020136.
Immune Reconstitution Inflammatory Syndrome in children.
Mahomed N, Reubenson G
SA J Radiol. 2019; 21(2):1257.
PMID: 31754484
PMC: 6837832.
DOI: 10.4102/sajr.v21i2.1257.
Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G, Tsegaye A, Gebreegziabiher D, Aseffa A, Howe R
BMC Immunol. 2019; 20(1):35.
PMID: 31601184
PMC: 6788090.
DOI: 10.1186/s12865-019-0317-9.
Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment.
Riou C, Jhilmeet N, Rangaka M, Wilkinson R, Wilkinson K
J Infect Dis. 2019; 221(1):162-167.
PMID: 31419285
PMC: 6910879.
DOI: 10.1093/infdis/jiz417.
Response to First-Line Antiretroviral Therapy Among PLHIV from a High-Risk, Low-Prevalence Setting.
Rashed Ul Islam S, Jahan M, Nessa A, Tabassum S
J Int Assoc Provid AIDS Care. 2019; 18:2325958219867329.
PMID: 31392926
PMC: 6900579.
DOI: 10.1177/2325958219867329.
Thymic Function as a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy.
Rb-Silva R, Nobrega C, Azevedo C, Athayde E, Canto-Gomes J, Ferreira I
Front Immunol. 2019; 10:25.
PMID: 30804925
PMC: 6370619.
DOI: 10.3389/fimmu.2019.00025.
Power Estimation in Planning Randomized Two-Arm Pre-Post Intervention Trials with Repeated Longitudinal Outcomes.
Hu Y, Hoover D
J Biom Biostat. 2018; 9(3).
PMID: 30386678
PMC: 6207205.
DOI: 10.4172/2155-6180.1000403.